May S Kung Sutherland

Title: May S Kung Sutherland: Innovator in Bone Density Research

Introduction

May S Kung Sutherland is a notable inventor based in Bothell, WA (US). She has made significant contributions to the field of bone density research, holding 2 patents that focus on innovative methods to enhance bone health. Her work is particularly relevant in the context of treating conditions such as osteoporosis.

Latest Patents

Sutherland's latest patents revolve around the SOST gene, which produces sclerostin, a protein that induces apoptosis in bone progenitor cells. Her inventions provide antagonists to the sclerostin protein and methods for identifying new sclerostin antagonists. Additionally, she has developed molecules that can suppress the expression of the SOST gene, along with methods for identifying such molecules. These advancements are crucial for increasing bone mineralization in mammals, offering potential treatments for osteoporosis.

Career Highlights

Throughout her career, Sutherland has worked with prominent companies in the biotechnology sector, including Celltech R&D Limited and UCB Manufacturing, Inc. Her experience in these organizations has allowed her to refine her research and contribute to significant advancements in her field.

Collaborations

Sutherland has collaborated with esteemed colleagues such as James Charles Geoghegan and John A Latham. These partnerships have further enriched her research and innovation efforts.

Conclusion

May S Kung Sutherland is a pioneering inventor whose work in bone density research has the potential to transform treatment options for osteoporosis. Her innovative patents and collaborations highlight her commitment to advancing medical science.